Slow-Release 5-HTP Formulation for Serotonin Augmentation

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current treatments for psychiatric disorders associated with serotonergic dysregulation, such as depression and ADHD, often have limited efficacy, with serotonin reuptake inhibitors (SSRIs) only alleviating symptoms in about 50% of patients, and existing formulations of 5-hydroxytryptophan (5-HTP) suffer from rapid absorption and elimination, leading to side effects and suboptimal serotonin enhancement.

Innovation Solution

A sustained release formulation of 5-HTP is administered in combination with serotonin enhancers like SSRIs, MAOIs, or tricyclic antidepressants, providing a slow and controlled release to enhance extracellular serotonin levels and reduce side effects, potentially improving treatment outcomes for serotonergic neurotransmission dysregulation disorders.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Speed

If 5-HTP is administered as immediate release formulation, then rapid absorption and onset of action is achieved, but side effects increase and duration of action is insufficient

Engineering Contradiction:

Improveabsorption rateVSAvoidside effects

Core Design Contradiction:

SpeedVSObject-affected harmful factors

Solution Approach 1:

The patent divides the 5-HTP dosage into multiple smaller doses administered at different times throughout the day rather than a single large dose. This segmentation approach maintains adequate serotonin enhancement while reducing peak plasma concentrations that cause side effects, resolving the contradiction between rapid absorption and harmful effects.

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The patent implements periodic administration of 5-HTP at multiple dosing intervals throughout the day. This periodic action pattern maintains steady serotonin levels in the brain while avoiding the abrupt peaks and troughs associated with immediate release formulations, thereby reducing side effects while preserving efficacy.

Inventive Principle:

Principle #19Periodic action

2Speed

If 5-HTP is administered as immediate release formulation, then rapid absorption is achieved, but duration of action is insufficient

Engineering Contradiction:

Improveabsorption rateVSAvoidduration of action

Core Design Contradiction:

SpeedVSDuration of action of moving object

Solution Approach 1:

By segmenting the total daily dose into multiple smaller doses administered at different times, the patent extends the overall duration of action. Each small dose provides a prolonged effect, and the cumulative effect of multiple doses maintains serotonin enhancement throughout the day, resolving the contradiction between rapid absorption and insufficient duration.

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The patent ensures continuous serotonin enhancement by administering 5-HTP at multiple dosing intervals throughout the day. This continuous action pattern eliminates the gaps in therapeutic effect that occur with single-dose immediate release formulations, thereby extending the overall duration of action while maintaining adequate absorption rates.

Inventive Principle:

Principle #20Continuity of useful action

3Device complexity

If SSRI alone is used to treat depression, then treatment simplicity is maintained, but efficacy is insufficient in treatment-resistant cases

Engineering Contradiction:

Improvetreatment regimen complexityVSAvoidtreatment efficacy

Core Design Contradiction:

Device complexityVSReliability

Solution Approach 1:

The patent combines SSRI therapy with multiple 5-HTP doses in a unified treatment regimen. This merging of two therapeutic agents with complementary mechanisms of action (SSRI blocking reuptake, 5-HTP providing substrate) produces synergistic effects that enhance efficacy in treatment-resistant depression while maintaining manageable treatment complexity through a structured dosing schedule.

Inventive Principle:

Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The slow-release 5-HTP formulation effectively augments serotonin levels in the brain, enhancing the efficacy of serotonin enhancer therapies while minimizing side effects, thereby improving treatment outcomes for patients with treatment-resistant depression and other serotonergic disorders.

Implementation Method 1

5-hydroxytryptophan (5-HTP), for use in treating a psychiatric disorder... wherein said 5-HTP is provided as a sustained release formulation

Methodology Applied

Scientific EffectSustained release:

Implementation Method 2

5-hydroxytryptophan (5-HTP)... enhance the efficacy of pro-serotonergic medications... effectively augments serotonin levels in the brain

Methodology Applied

Scientific EffectEnzymatic conversion: Enzyme

Data Source

PatentEP2629615B1Slow-release formulations of 5-hydroxytryptophan as an adjunct to pro-serotonergic therapies

Publication Date: 2018.10.10 DUKE UNIV

Figure 1~2A
Figure 2B~3A
Figure 3B~4

AI summary

The present invention concerns the treatment of serotonergic dyregulation disorders and/or augmentation of serotonin levels in the brain by add-on treatments to serotonin enhancers, and slow-release formulations of 5-hydroxytryptophan (5-HTP) therefor.